Patent · US Active

Composite structural material and pharmaceutical composition thereof

US10507185B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

INNOVACO PHARMACEUTICALS, INC. · CN

Inventors

William Wei · Williamston, US
Herling Uang · Somerville, US

Key dates

Filing date	Sep 25, 2015
Grant date	Dec 17, 2019
Priority date	—
Expiry date	Sep 25, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A composite structural material and pharmaceutical composition comprising same, the use of the composite structural material in preparing a sustained release formulation, and a pharmaceutical composition formulation method; the composite structural material comprises a hydrophobic structural material and a hydrophilic structural material; the proportion of the hydrophobic structural material to the hydrophilic structural material ranges from 1:0.01 to 1:5, preferably 1:0.05 to 1:4, more preferably 1:0.1 to 1:3, and most preferably 1:0.4 to 1:2, such as 1:0.4 to 1:1.3. The pharmaceutical composition comprises the composite structural material and one or more active pharmaceutical ingredients, and preferably the proportion of the composite structural material to the active pharmaceutical ingredients ranges from 1:0.01 to 1:8, more preferably 1:0.02 to 1:5, and most preferably 1:0.03 to 1:1, such as 1:0.3 to 1:0.7.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.